QUANTUM GENOMICS

Patent Applications and Registrations

Patent applications and USPTO patent grants for QUANTUM GENOMICS.The latest application filed is for "compounds and compositions comprising the same for treating hypertension or heart failure".

Company Profile

1.13.8

QUANTUM GENOMICS - Paris FR
QUANTUM GENOMICS - Massy N/A FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds and compositions comprising the same for treating hypertension or heart failure Grant 11,345,658 - Balavoine , et al. May 31, 2	2022-05-31
Compounds And Compositions Comprising The Same For Treating Hypertension Or Heart Failure App 20220041548 - BALAVOINE; FABRICE ; et al.	2022-02-10
Aminopeptidase A inhibitors and pharmaceutical compositions comprising the same Grant 11,192,907 - Balavoine , et al. December 7, 2	2021-12-07
Novel Aminophosphinic Derivatives As Aminopeptidase A Inhibitors App 20210309677 - BALAVOINE; FABRICE ; et al.	2021-10-07
Aminopeptidase A Inhibitors And Pharmaceutical Compositions Comprising The Same App 20210309678 - BALAVOINE; FABRICE ; et al.	2021-10-07
Combination of (3S,3S') 4,4'-disulfanediylbis(3-aminobutane 1-sulfonic acid) and a second antihypertensive agent Grant 10,959,938 - Llorens-Cortes , et al. March 30, 2	2021-03-30
Crystalline phase of (3S,3S') 4,4'-disulfanediylbis(3-aminobutane 1-sulfonic acid) with L-lysine Grant 9,487,477 - Balavoine , et al. November 8, 2	2016-11-08
Crystalline Phase Of (3s,3s') 4,4'-disulfanediylbis(3-aminobutane 1-sulfonic Acid) With L-lysine App 20160221940 - Balavoine; Fabrice ; et al.	2016-08-04
Method for the preparation of (3S,3S') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic acid) Grant 9,340,497 - Balavoine , et al. May 17, 2	2016-05-17
Crystalline phase of (3S.3S') 4,4'-disulfanediylbis(3-aminobutane 1-sulfonic acid) with L-lysine Grant 9,278,921 - Balavoine , et al. March 8, 2	2016-03-08
Method For The Preparation Of (3s,3s') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic Acid) App 20160046571 - BALAVOINE; Fabrice ; et al.	2016-02-18
Method for the preparation of (3S, 3S') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic acid) Grant 9,187,418 - Balavoine , et al. November 17, 2	2015-11-17
Combination Of (3s,3s') 4,4'-disulfanediylbis(3-aminobutane 1-sulfonic Acid) And A Second Antihypertensive Agent App 20150320703 - Llorens-Cortes; Catherine ; et al.	2015-11-12
Crystalline Phase Of (3s.3s') 4,4'-disulfanediylbis(3-aminobutane 1-sulfonic Acid) With L-lysine App 20150284325 - Balavoine; Fabrice ; et al.	2015-10-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.